Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,376 | -26,745 | -19,601 | -11,040 | -63,118 |
| Depreciation Amortization | 621 | 527 | 367 | 190 | -834 |
| Other Working Capital | -5,430 | -5,233 | -3,351 | -2,511 | -4,883 |
| Other Operating Activity | -1,665 | -1,243 | -377 | -4 | 7,546 |
| Operating Cash Flow | $-39,850 | $-32,694 | $-22,962 | $-13,365 | $-61,289 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,411 | 42,337 | 24,381 | 13,588 | 57,469 |
| PPE Investments | 891 | 891 | 963 | 963 | 107 |
| Investing Cash Flow | $44,302 | $43,228 | $25,344 | $14,551 | $57,576 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19 | 14 | 14 | N/A | 108 |
| Financing Cash Flow | $19 | $14 | $14 | $N/A | $108 |
| Beginning Cash Position | 8,970 | 8,970 | 8,970 | 8,970 | 12,575 |
| End Cash Position | 13,441 | 19,518 | 11,366 | 10,156 | 8,970 |
| Net Cash Flow | $4,471 | $10,548 | $2,396 | $1,186 | $-3,605 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,850 | -32,694 | -22,962 | -13,365 | -61,289 |
| Capital Expenditure | -72 | -72 | N/A | N/A | -41 |
| Free Cash Flow | -39,922 | -32,766 | -22,962 | -13,365 | -61,330 |